Movers and Shakers news roundup

  • 2 October 2020

This month’s Movers and Shakers features appointments at NHSX and the first winners of the Rewired Pitchfest, TestCard.

Clare Hawkins has been appointed as a senior advisor for community care at NHSX. Hawkins, who is currently CEO at Hertfordshire Community NHS Trust, will be part of the joining up care programme board.

NHSX’s CNIO, Natasha Phillips, said on social media that she was “delighted” to have Hawkins join the organisation.

“A fantastic appointment bringing a wealth of community nursing and leadership experience,” she added.

The founder of NHS Choices, Jonathon Carr-Brown, has joined Your.MD as chief operations officer.

The company are the creators of Healthily, a self-care app which gives people access to information, guidance and support for their health.

Carr-Brown forms a senior management team which includes CEO and co-founder, Matteo Berlucchi, along with medical director and former RCGP chair, Professor Maureen Baker.

Mark England has been named CEO of healthcare company HN.

England, who joined HN in October 2019, has develop new services and helped grow strategic partnerships.

Prior to working at HN, England was deputy national director for urgent and emergency care at NHS England and NHS Improvement.

He said: “After working at HN for a year, I have become more and more impressed by our dynamic staff, their expertise, commitment and the solutions they have developed.

“I am excited to have this opportunity to further our contribution to the patients we currently support, and also to work with new areas and systems to make proactive personalised care a reality in the NHS and beyond.”

Rewired Pitchfest winners, Testcard, has announced the arrival of four new senior managers.

Howard Meitiner, has been appointed chairman while  Andrew Vallance-Owen is the start-up’s new chief medical officer.

They will be joined by TestCard’s founder investor, Chris Craig-Wood, who has been appointed chief commercial officer and Simon Lints who is head of Asia Pacific.

Commenting on the appointments, TestCard CEO. Luke Heron. said, “We have been on an extraordinary journey over the past couple of years.

“These appointments to the board are a testament to the company’s ambition. All four bring an unrivalled wealth of knowledge and expertise, which will help TestCard continue to grow as it delivers its disruptive at-home healthcare solution to the market across multiple territories.”

And finally, Sensyne Health has appointed Michael Macdonnell as chief operating officer.

Michael was previously director of global deployment at Google Health. Prior to that he was the national director of system transformation and director of strategy at NHS England.

He said: “Sensyne is an exceptional opportunity: a company that combines social impact with the capabilities to effect real change in how healthcare is delivered.

“Data insights and digital therapeutics could bring about an era of proactive or anticipatory care and disrupt a model of medicine too often based on the average patient. By working and sharing value with our healthcare partners, we can build a game-changing portfolio of technologies that will improve care for patients in the NHS and around the world.”

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

34,000 medication errors reported last year despite investments in tech

34,000 medication errors reported last year despite investments in tech

Last year saw a total of 34,000 medication errors made, including 21 incidents leading to patient death, and a further 27 leading to serious harm.
Digital Health Coffee Time Briefing ☕ 

Digital Health Coffee Time Briefing ☕ 

Today's briefing includes the results of a study of Apple's digital asthma device and news about a future in which we all have a digital…
Matthew Gould joins ÂŁ480m FDP contract hopefuls Quantexa

Matthew Gould joins ÂŁ480m FDP contract hopefuls Quantexa

Former head of NHS digital policy Matthew Gould has joined Quantexa, one of the remaining bidders for the NHS’ £480m federated data platform.